PubMed中文版
| PubMed ID | 37459141 |
|---|---|
| 发表日期 | 2023-08-01 |
| 作者 | Sims JR, Zimmer JA, Evans CD, Lu M, Ardayfio P, Sparks J, Wessels AM, Shcherbinin S, Wang H, Monkul Nery ES, Collins EC, Solomon P, Salloway S, Apostolova LG, Hansson O, Ritchie C, Brooks DA, Mintun M, Skovronsky DM, TRAILBLAZER-ALZ 2 Investigators. |
| 文献标题 | Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial. |
| 原始出处 | JAMA |
| 影响因子 | 55 期刊引文指标 11.47 |
| PubMed ID | 31638686 |
|---|---|
| 发表日期 | 2019-10-01 |
| 作者 | Arvanitakis Z, Shah RC, Bennett DA. |
| 文献标题 | Diagnosis and Management of Dementia: Review. |
| 原始出处 | JAMA |
| 影响因子 | 55 期刊引文指标 11.47 |
| PubMed ID | 31564456 |
|---|---|
| 发表日期 | 2019-09-26 |
| 作者 | Long JM, Holtzman DM. |
| 文献标题 | Alzheimer Disease: An Update on Pathobiology and Treatment Strategies. |
| 原始出处 | Cell |
| 影响因子 | 42.5 期刊引文指标 7.99 |
| PubMed ID | 30022099 |
|---|---|
| 发表日期 | 2018-10-01 |
| 作者 | Biessels GJ, Despa F. |
| 文献标题 | Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. |
| 原始出处 | Nat Rev Endocrinol |
| 影响因子 | 40 期刊引文指标 4.95 |
| PubMed ID | 28872215 |
|---|---|
| 发表日期 | 2017-10-19 |
| 作者 | Lane CA, Hardy J, Schott JM. |
| 文献标题 | Alzheimer's disease. |
| 原始出处 | Eur J Neurol |
| 影响因子 | 3.9 期刊引文指标 1.23 |
| PubMed ID | 28959956 |
|---|---|
| 发表日期 | 2017-09-20 |
| 作者 | Shi Y, Yamada K, Liddelow SA, Smith ST, Zhao L, Luo W, Tsai RM, Spina S, Grinberg LT, Rojas JC, Gallardo G, Wang K, Roh J, Robinson G, Finn MB, Jiang H, Sullivan PM, Baufeld C, Wood MW, Sutphen C, McCue L, Xiong C, Del-Aguila JL, Morris JC, Cruchaga C, Alzheimer’s Disease Neuroimaging Initiative, Fagan AM, Miller BL, Boxer AL, Seeley WW, Butovsky O, Barres BA, Paul SM, Holtzman DM. |
| 文献标题 | ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. |
| 原始出处 | Nature |
| 影响因子 | 48.5 期刊引文指标 11.12 |
| PubMed ID | 27025652 |
|---|---|
| 发表日期 | 2016-06-01 |
| 作者 | Selkoe DJ, Hardy J. |
| 文献标题 | The amyloid hypothesis of Alzheimer's disease at 25 years. |
| 原始出处 | EMBO Mol Med |
| 影响因子 | 8.3 期刊引文指标 2.07 |
| PubMed ID | 24450891 |
|---|---|
| 发表日期 | 2014-01-01 |
| 作者 | Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR, Bapineuzumab 301 and 302 Clinical Trial Investigators. |
| 文献标题 | Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease. |
| 原始出处 | N Engl J Med |
| 影响因子 | 78.5 期刊引文指标 23.3 |
| PubMed ID | 24450890 |
|---|---|
| 发表日期 | 2014-01-01 |
| 作者 | Doody RS, Thomas RG, Farlow M, Iwatsubo T, Vellas B, Joffe S, Kieburtz K, Raman R, Sun X, Aisen PS, Siemers E, Liu-Seifert H, Mohs R, Alzheimer's Disease Cooperative Study Steering Committee, Solanezumab Study Group. |
| 文献标题 | Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease. |
| 原始出处 | N Engl J Med |
| 影响因子 | 78.5 期刊引文指标 23.3 |
| PubMed ID | 21852788 |
|---|---|
| 发表日期 | 2011-08-19 |
| 作者 | Karran E, Mercken M, De Strooper B. |
| 文献标题 | The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics. |
| 原始出处 | Nat Rev Drug Discov |
| 影响因子 | 101.8 期刊引文指标 13.95 |
| PubMed ID | 21778438 |
|---|---|
| 发表日期 | 2011-07-21 |
| 作者 | Gorelick PB, Scuteri A, Black SE, Decarli C, Greenberg SM, Iadecola C, Launer LJ, Laurent S, Lopez OL, Nyenhuis D, Petersen RC, Schneider JA, Tzourio C, Arnett DK, Bennett DA, Chui HC, Higashida RT, Lindquist R, Nilsson PM, Roman GC, Sellke FW, Seshadri S, American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia. |
| 文献标题 | Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. |
| 原始出处 | Stroke |
| 影响因子 | 8.9 期刊引文指标 2.27 |
| PubMed ID | 20139996 |
|---|---|
| 发表日期 | 2010-02-01 |
| 作者 | Frisoni GB, Frisoni GB, Fox NC, Jack CR, Scheltens P, Thompson PM. |
| 文献标题 | The clinical use of structural MRI in Alzheimer disease. |
| 原始出处 | Nat Rev Neurol |
| 影响因子 | 33.1 期刊引文指标 5.7 |
| PubMed ID | 17900536 |
|---|---|
| 发表日期 | 2007-08-19 |
| 作者 | Goel A, Kunnumakkara AB, Aggarwal BB. |
| 文献标题 | Curcumin as "Curecumin": from kitchen to clinic. |
| 原始出处 | Biochem Pharmacol |
| 影响因子 | 5.6 期刊引文指标 1.3 |
| PubMed ID | 16234500 |
|---|---|
| 发表日期 | 2005-10-01 |
| 作者 | Schneider LS, Dagerman KS, Insel P. |
| 文献标题 | Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. |
| 原始出处 | JAMA |
| 影响因子 | 55 期刊引文指标 11.47 |
| PubMed ID | 15829527 |
|---|---|
| 发表日期 | 2005-04-13 |
| 作者 | Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, Galasko D, Jin S, Kaye J, Levey A, Pfeiffer E, Sano M, van Dyck CH, Thal LJ, Alzheimer's Disease Cooperative Study Group. |
| 文献标题 | Vitamin E and donepezil for the treatment of mild cognitive impairment. |
| 原始出处 | N Engl J Med |
| 影响因子 | 78.5 期刊引文指标 23.3 |
| PubMed ID | 12771112 |
|---|---|
| 发表日期 | 2003-05-01 |
| 作者 | Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones BN, Assaf AR, Jackson RD, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J, WHIMS Investigators. |
| 文献标题 | Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. |
| 原始出处 | JAMA |
| 影响因子 | 55 期刊引文指标 11.47 |
| PubMed ID | 10932230 |
|---|---|
| 发表日期 | 2000-08-01 |
| 作者 | Bard F, Cannon C, Barbour R, Burke RL, Games D, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Lieberburg I, Motter R, Nguyen M, Soriano F, Vasquez N, Weiss K, Welch B, Seubert P, Schenk D, Yednock T. |
| 文献标题 | Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. |
| 原始出处 | Nat Med |
| 影响因子 | 50 期刊引文指标 11.03 |
| PubMed ID | 10408445 |
|---|---|
| 发表日期 | 1999-07-01 |
| 作者 | Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Liao Z, Lieberburg I, Motter R, Mutter L, Soriano F, Shopp G, Vasquez N, Vandevert C, Walker S, Wogulis M, Yednock T, Games D, Seubert P. |
| 文献标题 | Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. |
| 原始出处 | Nature |
| 影响因子 | 48.5 期刊引文指标 11.12 |
| PubMed ID | 10190820 |
|---|---|
| 发表日期 | 1999-03-01 |
| 作者 | Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. |
| 文献标题 | Mild cognitive impairment: clinical characterization and outcome. |
| 原始出处 | Arch Neurol |
| 影响因子 |
| PubMed ID | 9110909 |
|---|---|
| 发表日期 | 1997-04-01 |
| 作者 | Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, Woodbury P, Growdon J, Cotman CW, Pfeiffer E, Schneider LS, Thal LJ. |
| 文献标题 | A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. |
| 原始出处 | N Engl J Med |
| 影响因子 | 78.5 期刊引文指标 23.3 |